HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA requests comment

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic, Toiletry and Fragrance Association is requesting comment by March 30 on the new microbiology method "M-7: A Rapid Method for Preservation Testing of Water-Miscible Personal Care Products," trade group announces. The method details a screening test - to be used during product development - that "can quickly differentiate between preservative systems that may be capable of providing adequate preservation and those which have insufficient anti-microbial activity to protect the product," according to CTFA, which adds a word of caution: "It is not intended to provide the definitive information on the adequacy of preservation of the final formulation." The method will be included in the 2007 update of the CTFA Microbiology Guidelines that are part of the CTFA Technical Guidelines series...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014580

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel